Shaoxian Wu

418 total citations
27 papers, 294 citations indexed

About

Shaoxian Wu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shaoxian Wu has authored 27 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 19 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Shaoxian Wu's work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (8 papers). Shaoxian Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (8 papers). Shaoxian Wu collaborates with scholars based in China, United States and Taiwan. Shaoxian Wu's co-authors include Jingting Jiang, Binfeng Lu, Xiao Zheng, Changping Wu, Yuanyuan Fu, Lujun Chen, Jingfang Ju, Juan Liu, Runzi Sun and Hao Huang and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Cell Reports.

In The Last Decade

Shaoxian Wu

22 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoxian Wu China 10 148 137 115 60 21 27 294
Tzu-Sheng Hsu Taiwan 9 143 1.0× 128 0.9× 86 0.7× 84 1.4× 14 0.7× 21 314
Shuwei Liang Australia 5 123 0.8× 201 1.5× 139 1.2× 48 0.8× 7 0.3× 5 311
Liqiu Liao China 8 70 0.5× 252 1.8× 130 1.1× 87 1.4× 9 0.4× 17 342
Xiangbo Meng China 7 123 0.8× 184 1.3× 147 1.3× 50 0.8× 20 1.0× 12 358
Christine Pich-Bavastro Switzerland 11 79 0.5× 159 1.2× 101 0.9× 109 1.8× 24 1.1× 16 325
Shigekazu Murakami United States 6 77 0.5× 242 1.8× 137 1.2× 59 1.0× 23 1.1× 9 399
Dimitris C. Kanellis Denmark 10 62 0.4× 209 1.5× 85 0.7× 88 1.5× 20 1.0× 14 323
Gustav Jonsson Austria 6 158 1.1× 60 0.4× 159 1.4× 24 0.4× 13 0.6× 10 268
Clément Kerneur France 4 155 1.0× 131 1.0× 76 0.7× 27 0.5× 8 0.4× 5 274
Fangxue Yan United States 6 102 0.7× 190 1.4× 164 1.4× 62 1.0× 5 0.2× 6 331

Countries citing papers authored by Shaoxian Wu

Since Specialization
Citations

This map shows the geographic impact of Shaoxian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoxian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoxian Wu more than expected).

Fields of papers citing papers by Shaoxian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoxian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoxian Wu. The network helps show where Shaoxian Wu may publish in the future.

Co-authorship network of co-authors of Shaoxian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoxian Wu. A scholar is included among the top collaborators of Shaoxian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoxian Wu. Shaoxian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hao, Hongwei� Jiang, Shaoxian Wu, et al.. (2025). IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer. Cancer Immunology Immunotherapy. 74(9). 284–284.
2.
Dai, Wei, Shaoxian Wu, Qi Wang, et al.. (2025). Identification of MAGE-A10 specific T cell receptor promising in immunotherapy of hepatocellular carcinoma. International Journal of Biological Macromolecules. 315(Pt 1). 144243–144243.
3.
Jiao, Jing, You Wu, Shaoxian Wu, & Jingting Jiang. (2025). Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy. Current Treatment Options in Oncology. 26(3). 213–225.
4.
Liu, Zhilin, Shaoxian Wu, Wenting Zhang, et al.. (2024). Cordycepin mitigates dextran sulfate sodium-induced colitis through improving gut microbiota composition and modulating Th1/Th2 and Th17/Treg balance. Biomedicine & Pharmacotherapy. 180. 117394–117394. 8 indexed citations
5.
Gao, Xinran, Weiwei Fang, Shaoxian Wu, et al.. (2024). Cordycepin enhances the Anticancer efficacy of PD-L1 blockade by modulating the tumor microenvironment of colon cancer. European Journal of Pharmacology. 985. 177089–177089. 3 indexed citations
6.
Yang, Jiayi, Fang Zhang, Shaoxian Wu, et al.. (2024). Association of CD8+TILs co-expressing granzyme A and interferon-γ with colon cancer cells in the tumor microenvironment. BMC Cancer. 24(1). 869–869. 5 indexed citations
7.
Huang, Hao, Fang Zhang, Shaoxian Wu, et al.. (2024). Precursor exhausted CD8+T cells in colorectal cancer tissues associated with patient’s survival and immunotherapy responsiveness. Frontiers in Immunology. 15. 1362140–1362140. 7 indexed citations
8.
Liu, Ming, et al.. (2024). Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway. Journal of Translational Medicine. 22(1). 510–510. 4 indexed citations
9.
Wu, Shaoxian, Hongwei� Jiang, Fang Zhang, et al.. (2024). Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy. Cancer Immunology Immunotherapy. 73(8). 138–138. 4 indexed citations
10.
Wu, You, Jing Jiao, Shaoxian Wu, & J. Jiang. (2024). Strategies for the enhancement of IL-21 mediated antitumor activity in solid tumors. Cytokine. 184. 156787–156787. 1 indexed citations
11.
Wu, Shaoxian, Jing Jiao, Nuo Wang, et al.. (2024). Tregs ST2 deficiency enhances the abscopal anti-tumor response induced by microwave ablation. International Immunopharmacology. 143(Pt 2). 113330–113330. 2 indexed citations
12.
Wu, Shaoxian, Hao Huang, Runzi Sun, et al.. (2023). Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Research Communications. 3(8). 1460–1472. 8 indexed citations
13.
Chen, Lujun, Xiao Zheng, Hao Huang, et al.. (2023). Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy. International Immunopharmacology. 124(Pt A). 110786–110786. 12 indexed citations
14.
Zhang, Hongyu, Hao Huang, Shaoxian Wu, et al.. (2023). Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment. Medical Oncology. 40(10). 285–285.
15.
Wu, Shaoxian, Weiwei Fang, Lujun Chen, et al.. (2023). Cordycepin remodels the tumor microenvironment of colorectal cancer by down-regulating the expression of PD-L1. Journal of Cancer Research and Clinical Oncology. 149(19). 17567–17579. 11 indexed citations
16.
Huang, Hao, Ziyi Huang, Jiayi Yang, et al.. (2023). CD226 identifies functional CD8+T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer. Frontiers in Immunology. 14. 1150803–1150803. 14 indexed citations
17.
Wang, Weihong, Shaoxian Wu, Yixin Zhang, et al.. (2022). Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy. Cell Reports. 41(5). 111582–111582. 30 indexed citations
18.
Wu, Shaoxian, Runzi Sun, Bo Tan, et al.. (2021). The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy. Frontiers in Cell and Developmental Biology. 9. 779865–779865. 22 indexed citations
19.
Liu, Juan, Shaoxian Wu, Xiao Zheng, et al.. (2020). Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions. Scientific Reports. 10(1). 14749–14749. 76 indexed citations
20.
Chen, Lujun, Shaoxian Wu, Bin Xu, et al.. (2018). Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer. Cancer Cell International. 18(1). 144–144. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tzu-Sheng Hsu Breakdown of academic impact, for papers by Shuwei Liang Breakdown of academic impact, for papers by Liqiu Liao Breakdown of academic impact, for papers by Xiangbo Meng Breakdown of academic impact, for papers by Christine Pich-Bavastro Breakdown of academic impact, for papers by Shigekazu Murakami Breakdown of academic impact, for papers by Dimitris C. Kanellis Breakdown of academic impact, for papers by Gustav Jonsson Breakdown of academic impact, for papers by Clément Kerneur Breakdown of academic impact, for papers by Fangxue Yan
Rankless by CCL
2026